(3S,9S,12S,18S,27S,30S)-27-[(2S)-butan-2-yl]-25-ethyl-9-[(2-hydroxy-2-methylpropoxy)methyl]-1,4,6,6,10,16,19,22,31-nonamethyl-18-(3-methylbutoxymethyl)-3,30-bis(2-methylpropyl)-34-(piperidine-1-carbonyl)-12-[2-[4-(trifluoromethyl)phenyl]ethyl]-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotetratriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
C72H119F3N12O15 — CID 171917887
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3S,9S,12S,18S,27S,30S)-27-[(2S)-butan-2-yl]-25-ethyl-9-[(2-hydroxy-2-methylpropoxy)methyl]-1,4,6,6,10,16,19,22,31-nonamethyl-18-(3-methylbutoxymethyl)-3,30-bis(2-methylpropyl)-34-(piperidine-1-carbonyl)-12-[2-[4-(trifluoromethyl)phenyl]ethyl]-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotetratriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
(3S,9S,12S,18S,27S,30S)-27-[(2S)-butan-2-yl]-25-ethyl-9-[(2-hydroxy-2-methylpropoxy)methyl]-1,4,6,6,10,16,19,22,31-nonamethyl-18-(3-methylbutoxymethyl)-3,30-bis(2-methylpropyl)-34-(piperidine-1-carbonyl)-12-[2-[4-(trifluoromethyl)phenyl]ethyl]-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotetratriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone (PubChem CID 171917887) has the molecular formula C72H119F3N12O15 and a molecular weight of 1449.81 g/mol. Its IUPAC name is (3S,9S,12S,18S,27S,30S)-27-[(2S)-butan-2-yl]-25-ethyl-9-[(2-hydroxy-2-methylpropoxy)methyl]-1,4,6,6,10,16,19,22,31-nonamethyl-18-(3-methylbutoxymethyl)-3,30-bis(2-methylpropyl)-34-(piperidine-1-carbonyl)-12-[2-[4-(trifluoromethyl)phenyl]ethyl]-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotetratriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone.
Molecular Properties
| Compound Name | (3S,9S,12S,18S,27S,30S)-27-[(2S)-butan-2-yl]-25-ethyl-9-[(2-hydroxy-2-methylpropoxy)methyl]-1,4,6,6,10,16,19,22,31-nonamethyl-18-(3-methylbutoxymethyl)-3,30-bis(2-methylpropyl)-34-(piperidine-1-carbonyl)-12-[2-[4-(trifluoromethyl)phenyl]ethyl]-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotetratriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone |
|---|---|
| PubChem CID | 171917887 |
| Molecular Formula | C72H119F3N12O15 |
| Molecular Weight | 1449.81 g/mol |
| Exact Mass | 1448.89 |
| IUPAC Name | (3S,9S,12S,18S,27S,30S)-27-[(2S)-butan-2-yl]-25-ethyl-9-[(2-hydroxy-2-methylpropoxy)methyl]-1,4,6,6,10,16,19,22,31-nonamethyl-18-(3-methylbutoxymethyl)-3,30-bis(2-methylpropyl)-34-(piperidine-1-carbonyl)-12-[2-[4-(trifluoromethyl)phenyl]ethyl]-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotetratriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone |
| SMILES | CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)N(C)C(=O)CC(C(=O)N2CCCCC2)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)C(C)(C)NC(=O)[C@H](COCC(C)(C)O)N(C)C(=O)[C@H](CCc2ccc(C(F)(F)F)cc2)NC(=O)CN(C)C(=O)[C@H](COCCC(C)C)N(C)C(=O)CN(C)C(=O)CN(CC)C1=O |
| InChI | InChI=1S/C72H119F3N12O15/c1-21-48(9)61-68(98)86(22-2)41-59(90)79(14)40-60(91)82(17)56(43-101-35-32-45(3)4)65(95)80(15)39-57(88)76-51(31-28-49-26-29-50(30-27-49)72(73,74)75)64(94)84(19)55(42-102-44-70(10,11)100)63(93)78-71(12,13)69(99)85(20)53(37-47(7)8)66(96)83(18)54(67(97)87-33-24-23-25-34-87)38-58(89)81(16)52(36-46(5)6)62(92)77-61/h26-27,29-30,45-48,51-56,61,100H,21-25,28,31-44H2,1-20H3,(H,76,88)(H,77,92)(H,78,93)/t48-,51-,52-,53-,54?,55-,56-,61-/m0/s1 |
| InChIKey | DTBWBDXRQWSVMQ-MPTOMZCTSA-N |
| XLogP | 3.81 |
| TPSA | 308.78 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 15 |
| Rotatable Bonds | 20 |
| Heavy Atoms | 102 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1449.81 |
| LogP ≤ 5 | 3.81 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 15 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171917887 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.